Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer.
暂无分享,去创建一个
Claire E Bender | David Dingli | D. Dingli | S. Russell | A. R. Penheiter | C. Bender | S. K. Carlson | K. Classic | Stephen J Russell | Kelly L Classic | Alan R Penheiter | Troy R Wegman | Stephanie K Carlson | T. Wegman | A. Penheiter
[1] V. Lowe,et al. In Vivo Quantitation of Intratumoral Radioisotope Uptake Using Micro-Single Photon Emission Computed Tomography/Computed Tomography , 2006, Molecular Imaging and Biology.
[2] E. Galanis,et al. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress , 2007, Nature Clinical Practice Oncology.
[3] M. Billeter,et al. Rescue of measles viruses from cloned DNA. , 1995, The EMBO journal.
[4] T. Endo,et al. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. , 1997, Endocrinology.
[5] D. Tindall,et al. In vivo sodium iodide symporter gene therapy of prostate cancer , 2001, Gene Therapy.
[6] D. Kirn,et al. Gene therapy progress and prospects cancer: oncolytic viruses , 2008, Gene Therapy.
[7] S. Russell,et al. Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide Symporter , 2006, Clinical Cancer Research.
[8] A. Pinchera,et al. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. , 2006, The Journal of clinical endocrinology and metabolism.
[9] M. O’Connor,et al. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. , 2007, Human gene therapy.
[10] B. Kemp,et al. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. , 2009, AJR. American journal of roentgenology.
[11] E. Galanis,et al. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview. , 2009, Current opinion in molecular therapeutics.
[12] M. O’Connor,et al. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. , 2006, Human gene therapy.
[13] P. Opolon,et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. , 2000, Cancer research.
[14] C. Bassi,et al. Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives. , 2006, JOP : Journal of the pancreas.
[15] U. Haberkorn,et al. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] R. Vile,et al. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. , 2001, The Journal of clinical endocrinology and metabolism.
[17] T. Petrich,et al. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[18] S. H. Wollman,et al. Kinetics of accumulation of radio-iodine by thyroid gland: short time intervals. , 1962, The American journal of physiology.
[19] Li Zhu,et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non–small cell lung cancer , 2001, Cancer Gene Therapy.
[20] S. Russell,et al. Measles virus for cancer therapy. , 2009, Current topics in microbiology and immunology.
[21] D. Dingli,et al. In vivo imaging and tumor therapy with the sodium iodide symporter , 2003, Journal of cellular biochemistry.
[22] R. Mandell,et al. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. , 1999, Cancer research.
[23] Goulven Merer,et al. Small‐Molecule Inhibitors of Sodium Iodide Symporter Function , 2008, Chembiochem : a European journal of chemical biology.
[24] L. Mollet,et al. A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice , 2003, Journal of Virology.
[25] S. Russell,et al. Measles virus as an oncolytic vector platform. , 2008, Current gene therapy.
[26] David Dingli,et al. Genetically targeted radiotherapy for multiple myeloma. , 2003, Blood.
[27] D. Trono,et al. Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.
[28] G. Gores,et al. Treatment options for hepatobiliary and pancreatic cancer. , 2007, Mayo Clinic proceedings.
[29] S. Derbré,et al. Synthesis and evaluation of photoreactive probes to elucidate iodide efflux in thyrocytes. , 2009, Bioorganic & medicinal chemistry letters.
[30] D. Dingli,et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. , 2004, Blood.
[31] Christoph Michalski,et al. Pancreatic Cancer: From Bench to 5-Year Survival , 2006, Pancreas.
[32] H. Sakahara,et al. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] Stephen L. Brown,et al. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[34] D. Tindall,et al. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. , 2000, Cancer research.
[35] N. LaRusso,et al. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma , 2006, Hepatology.
[36] D. Kirn,et al. Oncolytic adenoviruses for cancer gene therapy. , 2008, Methods in molecular biology.